EUVIMEDEUVIMED entdecken
Crossref

Liver Transplantation for Gestational Alloimmune Liver Disease: Outcomes Analysis From Retrospective Cohort and National Case Series

Chun-Sing Huang iD, Naseem Ravanbakhsh iD, Shreya Tamma, Emma Hills, Sarah Van Winkle iD, Eric Lee iD, Annika Agnihotri iD, Rayhan Jhanji iD, Anna M Banc-Husu iD, Daniel H Leung, Moreshwar S Desai iD, George Mazariegos iD und 6 weitere

Pediatric Transplantation · 2026

DOI: 10.1111/petr.70470 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, 2026. Verfasst von Chun-Sing Huang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Department of Pediatric Surgery, Texas Children's Hospital, Baylor C…. Hauptthemen laut MEDLINE: Liver Transplantation, Hemochromatosis, Liver Failure, Acute, Liver Diseases. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gestational alloimmune liver disease is the most common cause of acute liver failure in neonates. Treatment includes exchange transfusion and IVIG, though a subset of neonates requires liver transplantation for survival.

Methods

We conducted a retrospective study using the Organ Procurement and Transplantation Network database and an institutional case series to characterize waitlist outcomes and patient survival among transplanted patients with gestational alloimmune liver disease.

Results

81 candidates were registered on the liver transplant waitlist with a neonatal hemochromatosis diagnosis code from October 1987 through March 2025. Of these, 36 (44.4%) received a liver transplant. Re‐transplantation was required in 6 (16.7%) patients. Four patients developed graft failure within the first year of transplant, 3 (75%) of which were due to hepatic artery thrombosis. Patient survival was 88.8% at 30 days, 82.7% at 1 year, and 79.5% at 5 years. Of the 45 candidates (55.6%) who did not receive a transplant, 20 (24.7% of all listed) died on the waitlist, 15 (18.5%) experienced improvement and ultimately did not need transplant, 8 (9.9%) were too sick to transplant, 1 (1.2%) was removed for other reasons, and 1 (1.2%) was transferred to another center. Among the institutional case series, three neonates presented with acute liver failure with workup consistent with GALD. All three were listed as status 1A, underwent successful liver transplant, and are alive present day.

Conclusions

Liver transplant should be offered without hesitation for treatment‐refractory GALD. Early referral to a transplant center should occur simultaneously with initiation of medical therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationHemochromatosisLiver Failure, AcuteLiver DiseasesHumansRetrospective StudiesFemaleInfant, NewbornTreatment OutcomePregnancyMaleWaiting ListsGraft SurvivalInfant

Stichwörter der Autor:innen

OPTNgestational alloimmune liver diseaseliver transplantationneonatal hemochromatosisneonatal liver failure

Autor:innen und Institutionen

  • Division of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Department of Pediatric Surgery, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
  • Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.
  • School of Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Division of Critical Care, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA.
  • Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Advent Health Transplant Institute, Orlando, Florida, USA.

ORCID-Profile: Chun-Sing Huang, Naseem Ravanbakhsh, Sarah Van Winkle, Eric Lee, Annika Agnihotri, Rayhan Jhanji, Anna M Banc-Husu, Moreshwar S Desai, George Mazariegos, Kyle Soltys, Abbas Rana, Nhu Thao N Galván, John Goss

Zitieren

APA

Huang, C. S., Ravanbakhsh, N., Tamma, S., Hills, E., Winkle, S. V., Lee, E., Agnihotri, A., Jhanji, R., Banc-Husu, A. M., Leung, D. H., Desai, M. S., Mazariegos, G., Soltys, K., Angelis, M., Chin, T., Rana, A., Galván, N. T. N., & Goss, J. (2026). Liver Transplantation for Gestational Alloimmune Liver Disease: Outcomes Analysis From Retrospective Cohort and National Case Series. Pediatric Transplantation. https://doi.org/10.1111/petr.70470

Vancouver

Huang CS, Ravanbakhsh N, Tamma S, Hills E, Winkle SV, Lee E, et al. Liver Transplantation for Gestational Alloimmune Liver Disease: Outcomes Analysis From Retrospective Cohort and National Case Series. Pediatric Transplantation. 2026. doi:10.1111/petr.70470

BibTeX
@article{Huang2026,
  author = {Huang, Chun-Sing and Ravanbakhsh, Naseem and Tamma, Shreya and Hills, Emma and Winkle, Sarah Van and Lee, Eric and Agnihotri, Annika and Jhanji, Rayhan and Banc-Husu, Anna M and Leung, Daniel H and Desai, Moreshwar S and Mazariegos, George and Soltys, Kyle and Angelis, Mike and Chin, Tom and Rana, Abbas and Galván, Nhu Thao N and Goss, John},
  title = {Liver Transplantation for Gestational Alloimmune Liver Disease: Outcomes Analysis From Retrospective Cohort and National Case Series},
  journal = {Pediatric Transplantation},
  year = {2026},
  doi = {10.1111/petr.70470}
}
Kostenlos starten →